carbamazepine
Generic: carbamazepine
Labeler: chartwell rx, llcDrug Facts
Product Profile
Brand Name
carbamazepine
Generic Name
carbamazepine
Labeler
chartwell rx, llc
Dosage Form
SUSPENSION
Routes
Active Ingredients
carbamazepine 100 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
62135-802
Product ID
62135-802_199bb366-8124-4f1f-e063-6294a90a231b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075714
Listing Expiration
2026-12-31
Marketing Start
2002-06-05
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
62135802
Hyphenated Format
62135-802
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
carbamazepine (source: ndc)
Generic Name
carbamazepine (source: ndc)
Application Number
ANDA075714 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/5mL
Packaging
- 2 TRAY in 1 BOX (62135-802-24) / 10 PACKAGE in 1 TRAY / 5 mL in 1 PACKAGE (62135-802-45)
- 450 mL in 1 BOTTLE (62135-802-53)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "199bb366-8124-4f1f-e063-6294a90a231b", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "upc": ["0362135802530"], "unii": ["33CM23913M"], "rxcui": ["308976"], "spl_set_id": ["8d5ace90-983b-48c4-baf1-b44f6af146de"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TRAY in 1 BOX (62135-802-24) / 10 PACKAGE in 1 TRAY / 5 mL in 1 PACKAGE (62135-802-45)", "package_ndc": "62135-802-24", "marketing_start_date": "20240528"}, {"sample": false, "description": "450 mL in 1 BOTTLE (62135-802-53)", "package_ndc": "62135-802-53", "marketing_start_date": "20231201"}], "brand_name": "Carbamazepine", "product_id": "62135-802_199bb366-8124-4f1f-e063-6294a90a231b", "dosage_form": "SUSPENSION", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "62135-802", "generic_name": "Carbamazepine", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbamazepine", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "100 mg/5mL"}], "application_number": "ANDA075714", "marketing_category": "ANDA", "marketing_start_date": "20020605", "listing_expiration_date": "20261231"}